Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert W Leong

Showing results (21-30 of 157) with videos related to

Pageof 16
Sort By:
Expert Opinion on Drug Safety|January 7, 2021
Use of medications during pregnancy and breastfeeding for Crohn's disease and ulcerative colitisRobyn Laube, Sudarshan Paramsothy, Rupert W Leong
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 27, 2021
Combination Therapy of Immunomodulators With Non-Anti-Tumor Necrosis Factor Agents in Inflammatory Bowel Disease: Need More Evidence?Aviv Pudipeddi, Sudarshan Paramsothy, Rupert W Leong
Therapeutic Advances in Gastroenterology|May 28, 2021
Review of pregnancy in Crohn's disease and ulcerative colitisRobyn Laube, Sudarshan Paramsothy, Rupert W Leong
World Journal of Gastroenterology|February 28, 2014
Epidemiological studies of migration and environmental risk factors in the inflammatory bowel diseasesYanna Ko, Rhys Butcher, Rupert W Leong
Hepatobiliary Surgery and Nutrition|August 25, 2020
Faecal microbiota transplantation as an elixir of youthCraig Haifer, Sudarshan Paramsothy, Rupert W Leong
Expert Opinion on Drug Safety|May 10, 2011
Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel diseaseChristian P Selinger, Andrew Robinson, Rupert W Leong
Journal of Crohn'S & Colitis|July 2, 2014
One size fits all? Choosing the right format to convey statistical informationChristian P Selinger, Rupert W Leong, John McLaughlin
The American Journal of Gastroenterology|January 9, 2025
Infliximab and Adalimumab in the Treatment of Fistulizing Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC4) StudyJohn David Chetwood, Sudarshan Paramsothy, Rupert W Leong
Alimentary Pharmacology & Therapeutics|March 24, 2024
Letter: Thioguanine, an underutilised option in inflammatory bowel disease?John D Chetwood, Sudarshan Paramsothy, Rupert W Leong
European Journal of Gastroenterology & Hepatology|January 20, 2022
Early thiopurine maintenance and reduced colectomy rate in ulcerative colitis: fact or fiction?Fardi H Mourad, Rupert W Leong, Viraj C Kariyawasam
Pageof 16

Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
Expert Opinion on Drug Safety|January 7, 2021
Use of medications during pregnancy and breastfeeding for Crohn's disease and ulcerative colitisRobyn Laube, Sudarshan Paramsothy, Rupert W Leong
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 27, 2021
Combination Therapy of Immunomodulators With Non-Anti-Tumor Necrosis Factor Agents in Inflammatory Bowel Disease: Need More Evidence?Aviv Pudipeddi, Sudarshan Paramsothy, Rupert W Leong
Therapeutic Advances in Gastroenterology|May 28, 2021
Review of pregnancy in Crohn's disease and ulcerative colitisRobyn Laube, Sudarshan Paramsothy, Rupert W Leong
World Journal of Gastroenterology|February 28, 2014
Epidemiological studies of migration and environmental risk factors in the inflammatory bowel diseasesYanna Ko, Rhys Butcher, Rupert W Leong
Hepatobiliary Surgery and Nutrition|August 25, 2020
Faecal microbiota transplantation as an elixir of youthCraig Haifer, Sudarshan Paramsothy, Rupert W Leong
Expert Opinion on Drug Safety|May 10, 2011
Clinical impact and drivers of non-adherence to maintenance medication for inflammatory bowel diseaseChristian P Selinger, Andrew Robinson, Rupert W Leong
Journal of Crohn'S & Colitis|July 2, 2014
One size fits all? Choosing the right format to convey statistical informationChristian P Selinger, Rupert W Leong, John McLaughlin
The American Journal of Gastroenterology|January 9, 2025
Infliximab and Adalimumab in the Treatment of Fistulizing Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC4) StudyJohn David Chetwood, Sudarshan Paramsothy, Rupert W Leong
Alimentary Pharmacology & Therapeutics|March 24, 2024
Letter: Thioguanine, an underutilised option in inflammatory bowel disease?John D Chetwood, Sudarshan Paramsothy, Rupert W Leong
European Journal of Gastroenterology & Hepatology|January 20, 2022
Early thiopurine maintenance and reduced colectomy rate in ulcerative colitis: fact or fiction?Fardi H Mourad, Rupert W Leong, Viraj C Kariyawasam
Pageof 16